ArticleNeuro-oncology practice2024

Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.

Margaret Shatara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.